Elmiron & Blindness

During these unprecedented times, Clark, Perdue, & List Co, LPA is here to fully support your needs in a timely and safe manner. COVID-19 should not affect your ability to investigate a personal injury case. We currently remain open and are still accepting new cases. With your safety top of mind, we are scheduling all meetings via telephone or video conference at this time.

Clark Perdue is proud of its decades long of counsel relationship with Anapol Weiss.  The collaborative effort between our firms has proven effective time and again in the representation of our mutual clients.

We are pleased to announce that Anapol Weiss’ Senior Associate Paola Pearson has been appointed to the Executive Committee for the national Elmiron Product Liability MDL. Paola was also named Pennsylvania State Court Liaison.

Elmiron is a popular medication used to treat interstitial cystitis and painful bladder syndrome.  Because it has been on the market for years, it has been prescribed to hundreds of thousands of American consumers.

The drug has recently been associated with a significantly increased risk of pigmentary maculopathy, which results from chronic and permanent damage to the retina. Injuries can range from irreparable vision impairment to blindness, which can progress even after patients stop taking the drug.

Specific diagnoses and side effects of Elmiron include:

  • Blindness (bilateral)
  • Blurred vision
  • Macular degeneration
  • Pattern Dystrophy
  • Pigmentary maculopathy
  • Vision disturbances
  • Vision impairment
  • Vision loss

We are privileged to work with Paola and her team–seeking compensation for consumers who have suffered Elmiron injury.¬† Please contact us if you would like more information.